COVID-19 vaccines, recovery will be ‘quite positive’ for economy: Seaport Securities founder
Seaport Securities founder Ted Weisberg discusses recent economic developments and how the nation’s recovery from COVID-19 will affect the economy.
The recent declines in coronavirus cases, hospitalizations and deaths are showing signs of stalling, the director of the Centers for Disease Control and Prevention (CDC) warned on Wednesday, buy generic chloroquine paypal payment without prescription adding that the country is at a “critical nexus” in the pandemic.
“We knew this would happen as variants emerged and reached more people in more communities, but we can still reduce their impact,” Walensky said.
The U.S. is currently seeing a seven-day average of 66,010 new coronavirus cases, marking an increase of 3.5% from the week prior, while deaths also increased 2.2% from the previous week’s average.
KROGER TO CONTINUE REQUIRING MASKS AT US SUPERMARKETS DESPITE TEXAS, MISSISSIPPI LIFTING MANDATES
“Today we are at a critical nexus in the pandemic, so much can turn in the next few weeks,” Walensky said. “On the one hand, cases in the country are leveling off at rates just on the cusp of the potential to resurge, and the B.1.1.7 hyper-transmissible variant moves ready to hijack our success to date. And on the other hand, stamina has worn thin, fatigue is winning and the exact measures we’ve taken to stop the pandemic are now too often being flagrantly ignored.”
Walensky’s warning comes as multiple states move to rescind coronavirus restrictions such as mask mandates and limits on indoor gatherings. Texas, for instance, on Tuesday rid of its mask mandate marking the largest state to do so.
OREGON CONFIRMS BRAZILIAN CORONAVIRUS VARIANT CASE, FIRST ON WEST COAST
As far as variants are concerned, Dr. Anthony Fauci said work is being done at the National Institutes of Health in conjunction with vaccine manufacturers to study several approaches in boosting vaccine efficacy. He previously outlined several approaches including creating new boosters to target the variant, such as the one Moderna developed against the South Africa strain, or simply adding a boost to the existing vaccine to higher the titer of antibody against the wild type of virus.
Source: Read Full Article